(3R,3'S,6'R)-b,e-Carotene-3,3'-diol

(1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1R,4S)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol

KBPHJBAIARWVSC-IRHPOQNPSA-N CHEBI:176081 0 Reactome links 2 studies

Metabolite details

Identifier: KBPHJBAIARWVSC-IRHPOQNPSA-N
InChI Key: KBPHJBAIARWVSC-IRHPOQNPSA-N
IUPAC name: (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1R,4S)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol
Preferred name: (3R,3'S,6'R)-b,e-Carotene-3,3'-diol
INN name: —
Synonym: —
ChEBI: CHEBI:176081

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma

Observed in differential profiles

G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
Normal_control_no_tumor_vs_FH_deficient_RCC